AI assistant
CONMED Corp — Director's Dealing 2014
Sep 4, 2014
31971_dirs_2014-09-04_62e27942-98b0-431f-b7d7-5a8fc27e21b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-09-02
Reporting Person: ABRAHAM WILLIAM (EVP-Business Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-02 | Common Stock | M | 10000 | $31.40 | Acquired | 11486 | Direct |
| 2014-09-02 | Common Stock | S | 10000 | $39.7564 | Disposed | 1486 | Direct |
| 2014-09-03 | Common Stock | M | 2500 | $19.93 | Acquired | 3986 | Direct |
| 2014-09-03 | Common Stock | F | 1702 | $39.89 | Disposed | 2284 | Direct |
| 2014-09-03 | Common Stock | M | 2500 | $29.92 | Acquired | 4784 | Direct |
| 2014-09-03 | Common Stock | F | 2102 | $39.89 | Disposed | 2682 | Direct |
| 2014-09-03 | Common Stock | M | 2500 | $26.69 | Acquired | 5182 | Direct |
| 2014-09-03 | Common Stock | F | 1972 | $39.89 | Disposed | 3210 | Direct |
| 2014-09-03 | Common Stock | M | 5000 | $16.46 | Acquired | 8210 | Direct |
| 2014-09-03 | Common Stock | F | 3124 | $39.89 | Disposed | 5086 | Direct |
| 2014-09-03 | Common Stock | M | 4000 | $19.26 | Acquired | 9086 | Direct |
| 2014-09-03 | Common Stock | F | 2679 | $39.89 | Disposed | 6407 | Direct |
| 2014-09-03 | Common Stock | M | 3000 | $27.63 | Acquired | 9407 | Direct |
| 2014-09-03 | Common Stock | F | 2411 | $39.89 | Disposed | 6996 | Direct |
| 2014-09-03 | Common Stock | M | 2000 | $26.09 | Acquired | 8996 | Direct |
| 2014-09-03 | Common Stock | F | 1559 | $39.89 | Disposed | 7437 | Direct |
| 2014-09-03 | Common Stock | M | 1000 | $32.93 | Acquired | 8437 | Direct |
| 2014-09-03 | Common Stock | F | 889 | $39.89 | Disposed | 7548 | Direct |
| 2014-09-04 | Common Stock | S | 6062 | $40.1594 | Disposed | 1486 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-02 | Options To Purchase Common Stock | $31.40 | M | 10000 | Disposed | 2015-05-17 | Common Stock (10000) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $19.93 | M | 2500 | Disposed | 2016-05-16 | Common Stock (2500) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $29.92 | M | 2500 | Disposed | 2017-05-17 | Common Stock (2500) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $26.69 | M | 2500 | Disposed | 2018-06-01 | Common Stock (2500) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $16.46 | M | 5000 | Disposed | 2019-06-01 | Common Stock (5000) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $19.26 | M | 4000 | Disposed | 2020-06-01 | Common Stock (4000) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $27.63 | M | 3000 | Disposed | 2021-06-01 | Common Stock (3000) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $26.09 | M | 2000 | Disposed | 2022-06-01 | Common Stock (2000) | Direct |
| 2014-09-03 | Sars (Stock Appreciation Rights) | $32.93 | M | 1000 | Disposed | 2023-06-01 | Common Stock (1000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $39.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.30. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F3: The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
F4: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
F5: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.